• 347
  • 336







Respiratory Drugs Market Research Reports

Respiratory drugs is a growing sector of the pharmaceuticals industry, and we have all the information resources that you need to be a leading player in this lucrative market. The publications listed under Research and Markets’ Respiratory Drugs category cover all drugs and therapeutics for conditions and diseases relating to the lungs and/or breathing, such as Acute Respiratory Distress Syndrome (ARDS), allergy, asthma, bronchitis, COPD (chronic obstructive pulmonary disease), cystic fibrosis, emphysema, lung disease, pneumonia, sinus infections, sleep apnea and others.

Our reports, books, and subscriptions will provide you with the latest industry news, forecasts, market trends and company profiles of market leaders and niche players including: Accentia Biopharmaceuticals, Aerogen, Aerovance, airPharma, AstraZeneca, Aventis Pharma, Bespak, Boehringer Ingelheim Pharmaceuticals, Cadila Pharmaceuticals, Dr. Reddys Laboratories, EvoGenix, GlaxoSmithKlineInyx, The Merck Generics Group, Novartis AG, Pfizer, Ranbaxy Laboratories, Respironics, Sandoz International, Schering-Plough, etc.

Publications on smoking cessation are listed under the OTC sub-category in the Pharmaceuticals section. Show Less
Read more

Chronic Obstructive Pulmonary Disease: Epidemiology and Patient-Based Market Forecasts, Treatment Algorithm, and Marketed and Pipeline Drug Analysis

While the chronic obstructive pulmonary disease (COPD) market will see downward pressure from the arrival of generic versions of key marketed brands, new products will drive positive growth during 2015-24. This...

Published:  April 2016
Price:  From

Asthma: Epidemiology and Patient-Based Market Forecasts, Treatment Algorithm, and Marketed and Pipeline Drug Analysis

The increasing availability of biologics will drive growth in the asthma market during 2015-24, but prescribing will be restricted to patients with severe persistent uncontrolled asthma. This report...

Published:  May 2016
Price:  From

Idiopathic Pulmonary Fibrosis: Epidemiology and Patient-Based Market Forecasts, Treatment Algorithm, and Marketed and Pipeline Drug Analysis

The FDA simultaneously approved both Esbriet and Ofev in October 2014, making them the first treatments specifically approved for IPF in the US. This report addresses the following questions: -...

Published:  January 2016
Price:  From

Copd Pricing, Reimbursement, and Access

In-class competition and generic entry provide payers with leverage to demand favorable pricing for inhalers in exchange for formulary access. This report addresses the following questions: -...

Published:  May 2016
Price:  From

Asthma Pricing, Reimbursement, and Access

Growth in the asthma market will be fueled by the introduction of new and expensive biologics, but companies will have to navigate access restrictions imposed by payers concerned about budget impact....

Published:  May 2016
Price:  From

COPD Drugs Market in China 2016-2020

About the Chronic Obstructive Pulmonary Disease (COPD) Drugs Market in China Chronic obstructive pulmonary disease (COPD) is a broad term that covers progressive lung diseases, including emphysema,...

Published:  June 2016
Price:  From

Global Chronic Obstructive Pulmonary Disease Drugs Market 2016-2020

About Chronic Obstructive Pulmonary Disease (COPD) COPD is a chronic disease condition with a combination of symptoms of both chronic bronchitis and emphysema. Chronic bronchitis results in inflammation...

Published:  July 2016
Price:  From

Global Asthma Therapeutics Market 2016-2020

About Asthma Therapeutics Increasing allergic rhinitis is a major factor for allergic asthma leading to increase in research for the development of allergic immunotherapies for the treatment of asthma....

Published:  July 2016
Price:  From

Global Allergic Rhinitis Drugs Market 2016-2020

About Allergic Rhinitis Drugs Allergic rhinitis is caused by the interaction of airborne allergens with specific immunoglobulin E (IgE) type antibodies on the surface of mast cells. This interaction...

Published:  February 2016
Price:  From

Global Alpha-1 Antitrypsin Drugs Market 2016-2020

About Alpha-1 antitrypsin Drugs Alpha-1 antitrypsin, also known as an alpha-1 protease inhibitor (A1PI), is a glycoprotein produced in the liver that helps in the inactivation of enzymes such as...

Published:  April 2016
Price:  From

Global Idiopathic Pulmonary Fibrosis 2016-2020

About Idiopathic Pulmonary Fibrosis Idiopathic pulmonary fibrosis belongs to a group of lung diseases known as interstitial lung diseases. It affects people in the age group 50-70 years. Diagnosis...

Published:  May 2016
Price:  From

Global Respiratory Drugs Market 2016-2020

About Respiratory Ailments Asthma, COPD, allergic rhinitis, pulmonary hypertension, cystic fibrosis, and IPF are some of the major respiratory diseases. Among these, asthma and COPD are the most...

Published:  May 2016
Price:  From

Global Preventive Asthma Drugs Market 2015-2019

About asthma According to the Global Initiative for Asthma, asthma is a chronic disease, which is characterized by wheezing, shortness of breath, chest tightness, and cough over a period of time. The...

Published:  October 2015
Price:  From

Global COPD and Asthma Devices Market - Industry Analysis 2015-2019

About COPD and asthma devices COPD and asthma devices are used for inhalation therapy. These devices convert drug suspensions or solutions into aerosolized particles, assisting in drug delivery in individuals...

Published:  October 2015
Price:  From

Amoxicillin (CAS 61336-70-7) Market Research Report 2016

This Global Report 2016 is a result of industry experts’ diligent work on researching the world market of amoxicillin. The report helps to build up a clear view of the market (trends and prospects),...

Published:  March 2016

2016-2020 US Respiratory Disease Market: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis

About This Report This new 283-page report from the publisher presents detailed analysis of the US Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza,...

Published:  March 2016
Price:  From

Orally Inhaled Bronchodilators to 2022

Asthma and COPD continue to be a health segments that present significant challenges to patients and the caregiver community. Patient adherence with prescribing instructions and treatment protocols...

Published:  April 2015
Price:  From

Asthma Drugs Market in the US 2015-2019

About asthma Asthma is a disease that affects the lungs and is characterized by wheezing, coughing, breathlessness, and chest tightness. It is a chronic ailment of the respiratory tract, which is...

Published:  June 2015
Price:  From

Cystic Fibrosis Market in Europe 2015-2019

About Cystic Fibrosis Cystic fibrosis, also known as mucoviscidosis, is a genetically inherited disease. The primary symptoms of cystic fibrosis include high salt content in the sweat, breathing difficulties,...

Published:  February 2015
Price:  From

Global COPD and Asthma Devices Market (Product Types and Geography) - Size, Share, Global Trends, Company Profiles, Analysis, Segmentation and Forecast, 2013 - 2020

The COPD and Asthma hold the largest market share within the global respiratory diseases’ market. As estimated by Global Initiative for Asthma (GINA), approximately 300 million people suffer from Asthma...

Published:  November 2014
Price:  From
Loading Indicator

Our Clients